BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27502248)

  • 1. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Baxter LC; Gaw N; Ranjbar S; Plasencia J; Dueck AC; Peng S; Smith KA; Nakaji P; Karis JP; Quarles CC; Wu T; Loftus JC; Jenkins RB; Sicotte H; Kollmeyer TM; O'Neill BP; Elmquist W; Hoxworth JM; Frakes D; Sarkaria J; Swanson KR; Tran NL; Li J; Mitchell JR
    Neuro Oncol; 2017 Jan; 19(1):128-137. PubMed ID: 27502248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Gaw N; Dueck AC; Smith KA; Nakaji P; Plasencia J; Ranjbar S; Price SJ; Tran N; Loftus J; Jenkins R; O'Neill BP; Elmquist W; Baxter LC; Gao F; Frakes D; Karis JP; Zwart C; Swanson KR; Sarkaria J; Wu T; Mitchell JR; Li J
    PLoS One; 2015; 10(11):e0141506. PubMed ID: 26599106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
    Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
    Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    Wang L; Wang H; D'Angelo F; Curtin L; Sereduk CP; Leon G; Singleton KW; Urcuyo J; Hawkins-Daarud A; Jackson PR; Krishna C; Zimmerman RS; Patra DP; Bendok BR; Smith KA; Nakaji P; Donev K; Baxter LC; MrugaĊ‚a MM; Ceccarelli M; Iavarone A; Swanson KR; Tran NL; Hu LS; Li J
    PLoS One; 2024; 19(4):e0299267. PubMed ID: 38568950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.
    Tang C; Guo J; Chen H; Yao CJ; Zhuang DX; Wang Y; Tang WJ; Ren G; Yao Y; Wu JS; Mao Y; Zhou LF
    Int J Clin Exp Pathol; 2015; 8(5):5327-35. PubMed ID: 26191234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma.
    Hu LS; Wang L; Hawkins-Daarud A; Eschbacher JM; Singleton KW; Jackson PR; Clark-Swanson K; Sereduk CP; Peng S; Wang P; Wang J; Baxter LC; Smith KA; Mazza GL; Stokes AM; Bendok BR; Zimmerman RS; Krishna C; Porter AB; Mrugala MM; Hoxworth JM; Wu T; Tran NL; Swanson KR; Li J
    Sci Rep; 2021 Feb; 11(1):3932. PubMed ID: 33594116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mutations associated with MRI-derived volumetric features in glioblastoma.
    Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ
    Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
    Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
    Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
    Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
    J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors.
    Rosenberg S; Verreault M; Schmitt C; Guegan J; Guehennec J; Levasseur C; Marie Y; Bielle F; Mokhtari K; Hoang-Xuan K; Ligon K; Sanson M; Delattre JY; Idbaih A
    Neuro Oncol; 2017 Feb; 19(2):219-228. PubMed ID: 27571888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
    Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
    Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiogenomic analysis of hypoxia pathway is predictive of overall survival in Glioblastoma.
    Beig N; Patel J; Prasanna P; Hill V; Gupta A; Correa R; Bera K; Singh S; Partovi S; Varadan V; Ahluwalia M; Madabhushi A; Tiwari P
    Sci Rep; 2018 Jan; 8(1):7. PubMed ID: 29311558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features.
    Gevaert O; Mitchell LA; Achrol AS; Xu J; Echegaray S; Steinberg GK; Cheshier SH; Napel S; Zaharchuk G; Plevritis SK
    Radiology; 2014 Oct; 273(1):168-74. PubMed ID: 24827998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A generalized parametric response mapping method for analysis of multi-parametric imaging: A feasibility study with application to glioblastoma.
    Lausch A; Yeung TP; Chen J; Law E; Wang Y; Urbini B; Donelli F; Manco L; Fainardi E; Lee TY; Wong E
    Med Phys; 2017 Nov; 44(11):6074-6084. PubMed ID: 28875538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiogenomics Profiling for Glioblastoma-related Immune Cells Reveals CD49d Expression Correlation with MRI parameters and Prognosis.
    Cho HR; Jeon H; Park CK; Park SH; Choi SH
    Sci Rep; 2018 Oct; 8(1):16022. PubMed ID: 30375429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images.
    Cui Y; Tha KK; Terasaka S; Yamaguchi S; Wang J; Kudo K; Xing L; Shirato H; Li R
    Radiology; 2016 Feb; 278(2):546-53. PubMed ID: 26348233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of intratumoral heterogeneity in high-grade glioma.
    Hu LS; Hawkins-Daarud A; Wang L; Li J; Swanson KR
    Cancer Lett; 2020 May; 477():97-106. PubMed ID: 32112907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
    Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
    Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.